UK markets open in 4 hours 59 minutes
NIKKEI 225
38,102.85 -126.26 (-0.33%) HANG SENG
18,863.46 -100.22 (-0.53%) CRUDE OIL
77.80 -0.46 (-0.59%) GOLD FUTURES
2,364.50 -10.50 (-0.44%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
49,024.30 +424.65 (+0.87%)
Sage Therapeutics, Inc. (SG7.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 04:05PM CEST
| Previous close | 11.43 |
| Open | 11.38 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 11.35 - 11.38 |
| 52-week range | 11.35 - 55.00 |
| Volume | |
| Avg. volume | 50 |
| Market cap | 683.367M |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.78 |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 85.05 |
Business WireSage Therapeutics to Participate in Upcoming May Investor Conferences
CAMBRIDGE, Mass., May 07, 2024--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in the following upcoming investor conferences in May:
Insider MonkeySage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.63. Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
Simply Wall St.Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates
Investors in Sage Therapeutics, Inc. ( NASDAQ:SAGE ) had a good week, as its shares rose 2.7% to close at US$13.69...
© 2024 Yahoo. All rights reserved.